European Medicines Agency (EMA)/European Generic medicines Association joint workshop on the impact of the revised EMA guideline on the pharmacokinetic and clinical evaluation of modified-release dosage forms

Date: 30/04/2015
Location: European Medicines Agency, London, UK

The workshop provides a platform to discuss the impact of the revised European Medicines Agency guideline on the pharmacokinetic and clinical evaluation of modified-release dosage forms. It aims at fostering a common understanding and interpretation of regulatory expectations before 1 June 2015, when the guideline comes into effect.

Documents

Multimedia

How useful was this page?

Add your rating